Hi-Clearance Inc. (TPEX: 1788)

Market Cap	6.17B
Revenue (ttm)	4.05B
Net Income (ttm)	370.20M
Shares Out	44.52M
EPS (ttm)	8.30
PE Ratio	16.68
Forward PE	n/a
Dividend	7.00 (5.05%)
Ex-Dividend Date	Jun 14, 2024

Volume	7,899
Open	138.50
Previous Close	138.50
Day's Range	138.50 - 139.00
52-Week Range	132.50 - 147.00
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Hi-Clearance

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysis centers; and sale and servi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1788

Financial Performance

In 2023, Hi-Clearance's revenue was 3.90 billion, a decrease of -16.93% compared to the previous year's 4.69 billion. Earnings were 347.98 million, a decrease of -5.03%.